Cargando…
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
BACKGROUND: The purpose of this study was to evaluate intravitreal bevacizumab as an adjuvant treatment to plaque brachytherapy in the treatment of choroidal melanoma. METHODS: This was a retrospective, consecutive study of 124 patients treated from 2007 to 2009 for choroidal melanoma with plaque br...
Autores principales: | Houston, Samuel K, Shah, Nisha V, Decatur, Christina, Lonngi, Marcela, Feuer, William, Markoe, Arnold M, Murray, Timothy G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557102/ https://www.ncbi.nlm.nih.gov/pubmed/23378737 http://dx.doi.org/10.2147/OPTH.S37938 |
Ejemplares similares
-
Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi, Marcela, et al.
Publicado: (2013) -
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
por: Shah, Nisha V, et al.
Publicado: (2012) -
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
por: Shah, Nisha V, et al.
Publicado: (2013) -
Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab
por: Cavalcante, Milena L, et al.
Publicado: (2014) -
Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
por: Shah, Nisha V, et al.
Publicado: (2012)